With this request for information, HUS launches a market consultation to prepare a procurement. The aim of this prior information notice is to find suppliers operating in this field of business, get information of the solutions available in the market, and inform our plans and requirements for the forthcoming procurement.
DESCRIPTION OF THE SUBJECT OF THE REQUEST FOR INFORMATION
HUS Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is a SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic and follow-up genetic testing services to all patients at Helsinki University Hospital area.
The genetics laboratory performs approximately 3 500 analyses per year using the ddPCR method, and the number is continuously increasing.
This Request for Information is released for preliminary evaluation and market research for potential ddPCR instrument suppliers.
INSTRUCTIONS FOR ANSWERING
Responses to this request for information must be submitted by email to kilpailutus.diagnostiikka@hus.fi no later than 18 March 2026. The subject line of the email must include: HUS 091-2026 ddPCR Instrument.
The response must include all the information requested below in sections 1–7. The respondent is also requested to provide a contact person and an email address for any potential subsequent one-to-one market dialogue and/or additional information requests from the contracting authority. Respondents may also attach any available brochures related to the proposed products or services.
Requirements to be addressed in the RFI Response:
1. Technology and Performance
1.1 What technology is the instrument based on (Droplet vs. Chip)?
1.2 Does the instrument support multiplexing? How many fluorescence channels are available?
1.3 Performance across different sample types (cell-free, whole blood, FFPE, bone marrow), including examples of analytical accuracy, sensitivity, and limits of detection.
1.4 How are detection limits determined for different sample matrices?
1.5 What types of analyses can be performed on the instrument? Examples: copy number analysis, genotyping, expression analysis, LOH, methylation.
2. Workflow, Capacity and Automation
2.1 Turnaround times for the instrument (including manual pipetting steps).
2.2 Instrument capacity: How many samples can be processed simultaneously?
2.3 Is droplet or chip generation automated?
3. Validation and References
3.1 Available validation data.
3.2 User references.
4. Instrument Configuration
4.1 Complete list of required components.
4.2 Reagents and mutation kits: Are they instrument specific or compatible with open systems?
4.3 Available kit sizes.
4.4 Availability of ready-to-use controls for assays.
4.5 Consumables: Are they instrument specific or compatible with open systems?
4.6 Availability and supply reliability.
4.7 CE-IVD marking.
5. Software and Data Management
5.1 Required software.
5.2 Required IT systems for instrument operation and data analysis. Are these included in the total price?
5.3 How is the analysis performed?
5.4 To what extent can raw data be processed by the user?
5.5 Can data be transferred to a LIMS system?
5.6 Supported file formats.
6. Maintenance and Support
6.1 Availability of local technical support.
6.2 Installation and training. Is a separate validation package available for the instrument?
7. Cost Estimate
7.1 Estimated costs for the instrument, maintenance, and consumables.
PAR-0000
REQUEST FOR INFORMATION: ddPCR Instrument.
With this request for information, HUS launches a market consultation to prepare a procurement. The aim of this prior information notice is to find suppliers operating in this field of business, get information of the solutions available in the market, and inform our plans and requirements for the forthcoming procurement.
DESCRIPTION OF THE SUBJECT OF THE REQUEST FOR INFORMATION
HUS Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is a SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic and follow-up genetic testing services to all patients at Helsinki University Hospital area.
The genetics laboratory performs approximately 3 500 analyses per year using the ddPCR method, and the number is continuously increasing.
This Request for Information is released for preliminary evaluation and market research for potential ddPCR instrument suppliers.
INSTRUCTIONS FOR ANSWERING
Responses to this request for information must be submitted by email to kilpailutus.diagnostiikka@hus.fi no later than 18 March 2026. The subject line of the email must include: HUS 091-2026 ddPCR Instrument.
The response must include all the information requested below in sections 1–7. The respondent is also requested to provide a contact person and an email address for any potential subsequent one-to-one market dialogue and/or additional information requests from the contracting authority. Respondents may also attach any available brochures related to the proposed products or services.
Requirements to be addressed in the RFI Response:
1. Technology and Performance
1.1 What technology is the instrument based on (Droplet vs. Chip)?
1.2 Does the instrument support multiplexing? How many fluorescence channels are available?
1.3 Performance across different sample types (cell-free, whole blood, FFPE, bone marrow), including examples of analytical accuracy, sensitivity, and limits of detection.
1.4 How are detection limits determined for different sample matrices?
1.5 What types of analyses can be performed on the instrument? Examples: copy number analysis, genotyping, expression analysis, LOH, methylation.
2. Workflow, Capacity and Automation
2.1 Turnaround times for the instrument (including manual pipetting steps).
2.2 Instrument capacity: How many samples can be processed simultaneously?
2.3 Is droplet or chip generation automated?
3. Validation and References
3.1 Available validation data.
3.2 User references.
4. Instrument Configuration
4.1 Complete list of required components.
4.2 Reagents and mutation kits: Are they instrument specific or compatible with open systems?
4.3 Available kit sizes.
4.4 Availability of ready-to-use controls for assays.
4.5 Consumables: Are they instrument specific or compatible with open systems?
4.6 Availability and supply reliability.
4.7 CE-IVD marking.
5. Software and Data Management
5.1 Required software.
5.2 Required IT systems for instrument operation and data analysis. Are these included in the total price?
5.3 How is the analysis performed?
5.4 To what extent can raw data be processed by the user?
5.5 Can data be transferred to a LIMS system?
5.6 Supported file formats.
6. Maintenance and Support
6.1 Availability of local technical support.
6.2 Installation and training. Is a separate validation package available for the instrument?
7. Cost Estimate
7.1 Estimated costs for the instrument, maintenance, and consumables.